GSK and Amgen are major biopharma players.
1 report, 1 independent
Updated Sep 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
GSK and Amgen are major biopharma players.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
GSK
British multinational pharmaceutical and biotechnology company
-
Amgen
American multinational biopharmaceutical company
Related events
- Amgen and Merck are currently competing against each other in the market for investor capital.
- A group of major pharmaceutical companies, including AbbVie, Bristol-Myers Squibb, Amgen, Pfizer, Moderna, and Merck, are noted as peers operating in the highly regulated pharmaceutical sector.
- Major pharmaceutical companies, including Pfizer, Amgen, Eli Lilly, and Novo Nordisk, are leading the market in next-generation GLP-1 drugs for weight loss and diabetes.
- Amgen Inc. trades on the NASDAQ stock exchange.
- Jack Leslie represents pharmaceutical firms like GSK and consulted for the Gates Foundation.